PharmaTimes -
April 2022

Strange days

In the past two years the battle against a faceless, merciless pandemic has raged throughout the world. Although casualties have been huge, the collective spirit of the global community, in combination with the astonishing creation of a life-affirming vaccine, has demonstrated that the forces of good are in excellent health. Or, at least, that’s what we thought.

Not many would have predicted that an even bigger crisis – an entirely preventable catastrophe – would take the focus away from COVID-19. And, yet, in 2022 war rages pointlessly and depressingly across European soil, for reasons no one can quite fathom.

This time there doesn’t seem to be an injectable solution, however. Not even the life sciences community can produce a vaccine that could prevent war or develop antidotes to missiles, tanks and shells.

But, as with the coronavirus, pharma will mobilise in the face of this new, exponentially increasing and constantly morphing challenge. The movement of people, in their millions, requires effective treatment – as much mental as physical. The trauma of brutal attacks and the impact of their aftermath will require precisely the same organisation and engagement that industry has demonstrated so brilliantly since March 2020.

A small positive to emerge from the recent events is that the majority of the human race and those within the life sciences ecosystem will not simply stand by. Indeed, early indications suggest that those forces of good I mentioned earlier are much stronger than anyone gave them credit for.

Enjoy the magazine.

April 2022 - magazine highlights

Thumbnail image for Pharma goes pop

Pharma goes pop

After centuries hidden away in the medicine cabinet our industry has finally entered the mainstream. Editor John Pinching fnds out how pharma has been injected into the collective public consciousness forever

Thumbnail image for Talking about an evolution

Talking about an evolution

A new healthcare universe has been expanding with strategic household branding, omnipresent metahealth and genuine soul at the heart of it

Thumbnail image for Come together

Come together

Abbey Road was the setting and music was the theme as the rare disease community convened to celebrate Rare Disease Day, raise awareness of Pompe disease and lay down a catchy tune

Thumbnail image for Fake news

Fake news

The fight against fake pharmaceuticals is unlocking a new era of commercial opportunity

Thumbnail image for Fashioning freedom

Fashioning freedom

Through her own experience of managing a chronic condition Victoria Jenkins wanted to go beyond conventional care by rewriting the dress code for patients

Thumbnail image for Getting together

Getting together

Industry landscape is evolving rapidly and successful partnerships are shaping the new terrain. Steffen Lang from Novartis explains how collaboration is changing pharma for the better

Thumbnail image for Design for life

Design for life

Reimagining workspaces – how COVID-19 and the life sciences’ ‘land rush’ have transformed workspace design

Thumbnail image for Change from within

Change from within

A growing UK life sciences sector has been key to developing innovationand boosting diversity

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download